CANNABIS SATIVA SUBSP. SATIVA FLOWERING TOP
Amyotrophic Lateral Sclerosis (ALS)
Ospedale San RaffaelemixturePhase 2/3Dormant
B
58/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 46/ 100
- Competitive Position
- 81/ 100
Competitive context
22 Active assets in the Amyotrophic Lateral Sclerosis (ALS) cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Mci-186 Tanabe Pharma Corporation | Phase 3 | BB |
L-Carnitine ChaodongWang | Phase 4 | BB |
Tvp-1012 Richard Barohn, MD | Phase 2 | B |
Masitinib AB Science | Phase 3 | B |
Mecobalamin Eisai Co., Ltd. | Phase 2/3 | B |
View all 36 →
Same molecule, other indications
CANNABIS SATIVA SUBSP. SATIVA FLOWERING TOP is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →